CCM
LVACW

Context Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Context Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-64,920
Closed – – 423
2022
Q4 		$0 Buy
+64,920
New +$3.19K ﹤0.01% 521
2022
Q2 		– Sell
-66,400
Closed -$23K – 691
2022
Q1 		$23K Buy
+66,400
New +$26.9K ﹤0.01% 570

Other funds holding LVACW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Context Capital Management's LVACW Position: Q1 2023 in Review

Context Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q1 2023, closing a stake of 64,920 shares.

Context Capital Management first reported a position in LVACW in Q1 2022 and held it in 2 quarters. The position peaked at $23K in Q1 2022. 33 funds tracked by Wall St. Rank hold LVACW as of Q1 2023.

  • Context Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q1 2023 after selling out during the quarter.
  • Context Capital Management sold 64,920 LAVA Medtech Acquisition Corp. Warrants shares in Q1 2023.
  • Context Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 2 quarters.
  • Context Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $23K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.